$SWISF Sekur Private Data Ltd. Achieves Customer

New Post Public Reply Private Reply Replies (0) Message Board
louied91
154
$SWISF Sekur Private Data Ltd. Achieves Customer Acquisition Cost "CAC" of US$32 for June 2023 Month to Date - Down 55% from April 2023 Cost of US$74 and Down 91% from Q1 2023

https://www.newsfilecorp.com/release/169841

Toronto, Ontario and New York, New York--(Newsfile Corp. - June 14, 2023) - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) ("Sekur" or the "Company" , a leading Swiss hosted secure and private communications platform, is pleased to announce that, since it has started optimization and SEO in January 2023, its Customer Acquisition Cost "CAC" was lowered to US$32 per Customer in June, month-to-date, while Life Time Value metrics "LTV" per customer has increased again.

In January 2023, The Company has embarked on a reduction of its Customer Acquisition Cost ("CAC" in order to focus on targeted digital marketing, such as Google Ads and META campaigns, and optimization of its Sekur website. Previously, the Company announced that is was targeting a CAC of US$75 or lower by the end of 2023, and a CAC of US$60 or lower for 2024 from direct marketing, not counting B2B partnerships, which would lower the CAC overall. The Company is targeting consumers and SMBs at this time and is improving its website content in order to inform SMBs and visitors on the benefits of using the Sekur privacy and security communications platform.

Alain Ghiai, CEO of Sekur Private Data, said: "We are very happy to be well ahead of our plans for our CAC reduction. The Company has a specific plan to tweak the CAC for the next quarter and increase the digital marketing budget gradually from August 2023 onward. Right now, if we count the money we are spending on digital marketing, and the organic growth from the SEO efforts, we are tracking a CAC of between US$30 to US$35. This is an amazing achievement in such a short time, and I want to congratulate our entire marketing team for their progress so far. A CAC of US$75 or lower is very attractive as we can scale and grow exponentially with the proper budgets put in place, and a CAC of under US$50 is extraordinary for us, so if we are under any of these numbers, we will do very well. Our prime directive is to provide private and secure communications for everyone, and, as we are not connected to any Big Tech platform, we offer a truly independent, private and secure means of communications without any data mining, through our proprietary technology and our secure servers based in Switzerland. We look forward to continuing to offer true data privacy to all individuals and their businesses and protect their intellectual property, and their privacy, from data miners and malicious hackers."

Since the Company has added SekurVPN and customized 'a-la-carte' bundles for consumers and businesses, approximately 50% of all customers have been buying bundles and 32% of customers purchased SekurVPN in the bundle or on its own.

On April 7th 2023, the Company launched its privacy VPN solution called SekurVPN, available through https://www.sekurvpn.com, or through https://www.sekur.com, and started commercial sales of its highly anticipated SekurVPN privacy and security VPN solution. The solution is also offered in USD, CAD, NZD, AUD, SGD, CHF, EUR and GPB. The Company plans to launch several videos on social media promoting SekurVPN in the coming weeks to select targeted audiences in the USA, and Australia. Recently Australia has been voted most hacked nation in the globe as of Q4 2022 according to this Cybersecutiy Connect article. The incident was discussed by Alain Ghiai, CEO of Sekur, in the latest Sekur Hack of the Week TV Episode on NewsmaxTV, Fox Business and on streaming media.

SekurVPN is especially meant for privacy enthusiasts and users wanting to protect their identity from hackers. An example would be users going to their e-banking or shopping online, using their emails, using messaging applications and wanting to have full privacy and protection from hackers hyjacking their IP location and signal. The service guarantees not to use Big Tech or Hyperscalers for its functioning or hosting, it guarantees that there are no third party bundles sold with it, so no data is leaked or sold to third parties, it guarantees no traffic pulling or monitoring, and no phone number required to register to the service.

According to a study and publication on forbes.com, 66% use a VPN to help protect personal data, 80% use a VPN for increased security and 33% use a VPN to mask their internet activity. More statistics can be found on this VPN Statistics And Trends In 2023 article.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading